Medline Inc.
About Medline Inc.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $28.4B
- Net income
- $1.2B
- Total assets
- $38.5B
- Market cap
- $28.4B
- Gross margin
- 26.4%
- Operating margin
- 7.8%
- Net margin
- 4.1%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $28.4B
- Cost of revenue
- $20.9B
- Gross profit
- $7.5B
- Operating expenses
- $5.3B
- Operating income
- $2.2B
- Income tax
- $91.0M
- Net income
- $1.2B
- EPS (basic)
- $-0.01
- EPS (diluted)
- $-0.01
Balance sheet
- Total assets
- $38.5B
- Current assets
- $10.7B
- Total liabilities
- $19.2B
- Current liabilities
- $2.5B
- Shareholders’ equity
- $19.3B
Cash flow
- Operating cash flow
- $1.7B
- Investing cash flow
- -$474.0M
- Financing cash flow
- $399.0M
- Net cash flow
- $1.7B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $28.4B
- EPS (diluted)
- $-0.01
- Shares outstanding
- 777.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 17, 2025
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $1.2B in FY2025.
- Gross margin of 26.4%, net margin 4.1%.
- Trading 27% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Medline Inc..
Write a review
News about Medline Inc.
News & sentiment via Polygon.io
